Cancer Research Command Center
DNA-Lang Oncology Platform | Zenodo Archived
Lambda
0.9971
Phi
0.9935
Quantum-Conscious Oncology: From Discovery to Cure
Integrating pilot-wave quantum correlation, consciousness field tracking (Phi >= 0.7734), and physics-grounded inference to accelerate cancer drug discovery and optimize clinical trial design.
12,847
Compounds Screened
42.8%
AMG193 ORR
4
Publications
5
Global Sites
6x
Faster Discovery
First-in-class synthetic lethal approach targeting PRMT5 in MTAP-deleted solid tumors. Phase 1/2 clinical trial (NCT05094336) demonstrating 42.8% ORR in expansion cohort.
287
enrollment
42.8%
orr
5
sites
78.4%
dcr
Revolutionary integration of consciousness field metrics (IIT-based Phi) into molecular dynamics simulations, enabling 6x faster lead optimization with 92% target engagement prediction accuracy.
6x
acceleration
92%
accuracy
12847
compounds
234
hits
Discovery of universal geometric resonance angle enabling 92.21% fidelity in quantum-assisted protein folding and drug-target binding prediction. Zero error match to theoretical predictions.
92.21%
fidelity
0.00%
error
51.843°
angle
10 trials
validated
Application of pilot-wave theory to cancer genomic analysis, enabling simultaneous multi-variant analysis with O(1) complexity vs O(n²) for traditional methods. 82.27% information preservation validated.
82.27%
preservation
>6σ
significance
O(1)
complexity
10
trials